Federal Agency to Cease Collection of Adverse Drug Reports
The Consumer Product Safety Commission will stop collecting data on injuries from adverse drug effects and other incidents like car accidents, according to a report from Reuters.
Tag: NIH/NIAID
All
Latest
Federal Agency to Cease Collection of Adverse Drug Reports
The Consumer Product Safety Commission will stop collecting data on injuries from adverse drug effects and other incidents like car accidents, according to a report from Reuters.
Read More
Tecovirimat Safe But Ineffective Against clade II mpox
The Study of Tecovirimat for Mpox (STOMP) began in September 2022 as part of the US whole-of-government response to the clade II mpox outbreak.
Read More
Cases of ME/CFS Increase Following COVID-19
COVID-19 infection may be associated with an increase in the number of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) cases.
Read More
$2M NIH Grant to Address Pseudomonas-Linked Lung Infections
Funds from NIH will advance ALX1 as a potential treatment in cystic fibrosis and other chronic lung diseases.
Read More
Federal Health Agencies Ordered to Halt Communications
The Trump Administration has ordered federal health agencies — The Food and Drug Administration, Centers for Disease Control and Prevention, and the National Institutes of Health — to “pause” all publicly issued external communications until February 1, 2025, according to multiple media outlets.
Read More
Experimental Vaccine Protects Mice Against Bird Flu Circulating in Cattle
The RNA-based vaccine showed full protection in mice against the H5N1 strain circulating in US cattle.
Read More
COVID-19 May Trigger Separate Chronic Condition Beyond Long COVID
New research suggests COVID-19 infection may lead to cases of a chronic condition, resembling but diagnostically separate from long COVID, characterized by persistent fatigue and post-exertional malaise.
Read More
$3.4M NIH Grant Expands School-Based Inhaler Program
A $3.4 million NIH grant will help expand and improve the Stock Inhaler for Schools program, which provides albuterol inhalers to students.
Read More
Four Keys to Controlling the Bird Flu Outbreak
National Institutes of Health officials have outlined four strategies for managing the H5N1 avian influenza outbreak.
Read More
Air Pollution Linked to Increased Risk of Venous Thromboembolism
The likelihood of VTE was linked to anywhere from a 39% to a more than two-fold increased risk based on long-term exposure to three different types of air pollutants.
Read More
NIH Trial Halts After Smallpox Drug Fails to Show Benefit for Mpox
A clinical trial testing a smallpox antiviral for mpox was halted after interim findings showed no efficacy in reducing lesion resolution or pain in mild to moderate cases.
Read More
Bird Flu Mutation Could Increase Human Transmission Risk
An NIH-funded study identified a mutation in the H5N1 avian influenza virus that enhances its ability to bind to human cells.
Read More
Wearable Prototype Monitors for Early Signs of COPD Flare-ups
Supported by a $1.2 million NIH grant, the multi-modal device will be tested in a clinical study involving 45 patients with COPD.
Read More
Mpox Vaccine Safe and Effective in Adolescents, Interim Analysis Shows
The NIH clinical trial aims to address a knowledge gap on mpox vaccine use in adolescent populations.
Read More
NIH and FDA Officials Urge New Approaches to Help Smokers Quit
New commentary emphasizes that engagement across stakeholders is critical to accelerate smoking cessation and reduce smoking-related disease and death.
Read More
COVID-19 Raises Heart Attack, Stroke Risk for Up to Three Years
Individuals infected with COVID-19 early in the pandemic faced an increased risk of heart attack, stroke, and death for up to three years following initial infection.
Read More
NIH Panel Provides Final COVID-19 Treatment Recommendations
Future updates to COVID-19 treatment recommendations will transition to professional medical societies.
Read More
Higher Buprenorphine Doses May Reduce Emergency Care Needs for Opioid Addiction
An NIH-funded analysis suggests higher doses of buprenorphine were associated with lower rates of emergency department visits or use of inpatient services related to behavioral health.
Read More
Metformin May Protect Against Long COVID in Diabetics
NIH-backed research reveals diabetics taking metformin have a lower risk of developing long COVID or dying after infection compared to those on other diabetes medications.
Read More
Blood Test Could Signal Future Risk of Severe Respiratory Conditions
The experimental blood test analyzes 32 proteins to predict an individual’s risk of developing severe lung diseases like COPD, offering potential for earlier intervention.
Read More
NIH to Host Virtual Workshop on Nutrition’s Role in Respiratory Health
The NIH’s Division of Lung Diseases will gather experts for a two-day virtual workshop to explore the role of nutrition in respiratory health and address key research challenges and opportunities.
Read More
Long COVID Symptoms Differ Between Younger Children and Adolescents
Adolescents were most likely to experience low energy/tiredness, while children were most likely to report headache.
Read More
Men and Women Really Do Experience the Flu Differently
Backed by a $3.8 million NIH grant, researchers are investigating how hormones impact influenza in men and women.
Read More
Lab Tests Unreliable for Long COVID Diagnosis
NIH-supported research finds that routine laboratory tests are not effective in diagnosing long COVID, highlighting the need for novel biomarkers that distinguish the condition from other ailments.
Read More